SANGAMO THERAPEUTICS, INC (SGMO) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.44 | +10.2% |
| 2024 | $-0.49 | +66.9% |
| 2023 | $-1.48 | -18.4% |
| 2022 | $-1.25 | -1.6% |
| 2021 | $-1.23 | -36.7% |
| 2020 | $-0.90 | -5.9% |
| 2019 | $-0.85 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.44 | +10.2% |
| 2024 | $-0.49 | +66.9% |
| 2023 | $-1.48 | -18.4% |
| 2022 | $-1.25 | -1.6% |
| 2021 | $-1.23 | -36.7% |
| 2020 | $-0.90 | -5.9% |
| 2019 | $-0.85 | — |